Title: Addiction Treatment Market
1Treatment Type - Alcohol Addiction Treatment,
Tobacco/Nicotine Addiction Treatment, Opioid
Addiction Treatment, Other Substance Addiction
Treatment Drug Type - Bupropion, Varenicline,
Acamprosate, Disulfiram, Naltrexone, Methadone,
Buprenorphine, Nicotine Replacement
ProductsForecast From 2019 - 2027
Addiction Treatment Market
2Table of Content
Sr. No. Content
Chapter 1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary Global Interventional Radiology Market
Chapter 4 Executive Summary Global Drug Discovery Informatics Market
Chapter 5 Market Overview
Chapter 6 Global Addiction Treatment Market Analysis and Forecasts, By Treatment Type
Chapter 7 Global Addiction Treatment Market Analysis and Forecasts, By Drug Type
Chapter 8 Global Addiction Treatment Market Analysis and Forecasts, By Treatment Centers
Chapter 9 Global Addiction Treatment Market Analysis and Forecasts, By Geography/Region
Chapter 10 North America Addiction Treatment Market Analysis and Forecast
Chapter 11 Europe Addiction Treatment Market Analysis and Forecast
Chapter 12 Asia Pacific Addiction Treatment Market Analysis and Forecast
Chapter 13 Latin America Addiction Treatment Market Analysis and Forecast
Chapter 14 Middle East Africa Addiction Treatment Market Analysis and Forecast
Chapter 15 Competition Landscape
3Addiction Treatment Market Snapshot
- Addiction treatment is intended to help an
individuals to prevent or stop compulsive
addicted products or drugs seeking. - Increase the customer pool, drug abuse treatment
providers and manufacturers of drug abuse
treatment products are focusing on creating
awareness among people and drug store owners
about adverse effects of drug abuse and
importance of abuse treatment - global addiction treatment market is classified
into alcohol addiction treatment,
tobacco/nicotine addiction treatment, opioid
addiction treatment and other substance addiction
treatment.
4(No Transcript)
5Reports Highlights
- global addiction treatment market was valued at
US 4.9 Bn in 2018 and is anticipated to expand
at a CAGR of 6.7 from 2019 to 2027 - Key Players
- Cipla Ltd., Allergan plc, Alkermes plc, Pfizer
Inc.,Orexo AB, GlaxoSmithKiline plc, Purdue
Pharma L.P, Mallinckrodt, and Reckitt Benckiser -
Request Sample
6(No Transcript)